SCOPE International is an international contract research organization (CRO) with a proven track record in successfully delivering phase I through phase IV studies in all major indications, including pediatric trials, orphan drugs, biologics, and medical devices, non-interventional studies (NIS), and post-authorization studies. Using our close connections with leading investigators and key opinion leaders, we believe in providing the highest quality solutions worldwide.
For the last 20 years, SCOPE has been at the forefront of delivering trials in Women’s Health, focusing on the many unmet medical needs and working to improve existing drug and device therapies in both reproductive health, age-related conditions, and other indications.
SCOPE has the distinct ability to consistently provide expertise to deliver the recruitment and treatment goals for Women’s Health clinical trials on time and on budget. In business since 2000, we have conducted more than 260 studies with over 70,000 patients worldwide. We have offices in 16 countries across Europe, Russia, Ukraine, and the USA operating with 250 permanent employees covering more than 30 countries and all major markets.